MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer

Pancreatology. 2009;9(6):793-6. doi: 10.1159/000199440. Epub 2010 Jan 28.

Abstract

Background: Biallelic MUTYH exon 7 and 13 mutations are associated with a high frequency of somatic K-ras gene guanine to thymine transversion mutations at codon 12 position 1 in MUTYH-associated polyposis patients who have increased risk of colon cancer. The purpose of this study was to determine if a similar association exists between exon 7 and 13 MUTYH mutations and pancreatic cancer.

Methods: Genomic DNA samples from 140 patients with pancreatic cancer and 107 controls were sequenced and analyzed for mutations in each of MUTYH exons 7 and 13.

Results: Two patients with pancreatic cancer were identified as heterozygous for a MUTYH Y165C germline mutation. One pancreatic cancer patient was heterozygous for a G382D mutation and an additional patient was heterozygous for a novel missense mutation, L406M. No biallelic mutations were identified in pancreatic cancer or control subjects.

Conclusion: Despite their association with somatic K-ras mutations and an increased risk of colorectal cancer in MUTYH-associated polyposis patients, MUTYH exon 7 and 13 mutations were not associated with pancreatic cancer in our cohort.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / genetics*
  • Cohort Studies
  • Colorectal Neoplasms / genetics
  • DNA Glycosylases / genetics*
  • Exons / genetics*
  • Female
  • Genes, ras
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Mutation, Missense
  • Pancreatic Neoplasms / genetics*
  • Syndrome

Substances

  • DNA Glycosylases
  • mutY adenine glycosylase